Suppr超能文献

尿生物标志物可在产前诊断单侧肾积水时存在超正常分肾功能的情况下识别肾盂成形术的需求。

Urinary biomarkers can identify the need for pyeloplasty in presence of supranormal differential renal function in antenatally diagnosed unilateral hydronephrosis.

机构信息

İstanbul University, İstanbul Faculty of Medicine, Department of Urology, Turkey.

İstanbul University, İstanbul Faculty of Medicine, Department of Urology, Division of Pediatric Urology, Turkey.

出版信息

J Pediatr Urol. 2022 Feb;18(1):6-12. doi: 10.1016/j.jpurol.2021.08.015. Epub 2021 Aug 21.

Abstract

INTRODUCTION

Decision for surgery can be challenging in children with AH (Antenatal Hydronephrosis) especially in the setting of supranormal differential renal function (SnDRF).

OBJECTIVE

Aim of this study is to investigate whether IP-10 (interferon gamma-induced protein 10), MCP-1 (monocyte chemotactic protein-1), NGAL (neutrophil gelatinase-associated lipocalin), CA 19-9 (carbohydrate antigen 19-9), and KIM-1 (kidney injury molecule-1) can identify the need for pyeloplasty in presence of SnDRF in antenatally diagnosed unilateral hydronephrosis.

STUDY DESIGN

A prospectively collected urinary biomarker database was used for the study. There was a total of 53 patients in the AH group. Nineteen children with no history of AH and a normal urinary ultrasonography were taken as controls. Patients with initial ipsilateral DRF (Differential Renal Function) over 50% were included in the SnDRF group while the remaining were named as non-SnDRF. Patients that didn't undergo surgery were classified as non-obstructive dilation (NOD) in both groups.

RESULTS

Pyeloplasty was performed in 6/20 patients in SnDRF group, and in 19/33 patients in non-SnDRF group. Biomarker levels in the pyeloplasty and NOD groups were not affected by the presence or absence of SnDRF (p = 1.00, for both). Urinary NGAL, and CA 19-9 could determine the need for surgery in SnDRF group with 83% and 100% sensitivity, 86% and 79% specificity, respectively whereas urinary IP-10 and KIM-1 could with 84% and 83% sensitivity, 57% and 71% specificity, respectively. Urinary MCP-1 could differentiate patients who underwent surgery with 83% sensitivity and 50% specificity in SnDRF groups.

CONCLUSION

Our results showed that biomarker levels were not affected whether the kidney has SnDRF. Furthermore, in patients with SnDRF, NGAL and CA 19-9 appear to better estimate requirement for surgical correction before deterioration of renal function.

摘要

简介

在患有产前肾积水(Antenatal Hydronephrosis,AH)的儿童中,尤其是在存在超正常肾差异功能(Supranormal Differential Renal Function,SnDRF)的情况下,手术决策可能具有挑战性。

目的

本研究旨在探讨 IP-10(干扰素γ诱导蛋白 10)、MCP-1(单核细胞趋化蛋白 1)、NGAL(中性粒细胞明胶酶相关脂质运载蛋白)、CA 19-9(碳水化合物抗原 19-9)和 KIM-1(肾损伤分子-1)是否可以识别在存在 SnDRF 的情况下,需要进行肾盂成形术的单侧产前肾积水患儿。

研究设计

本研究使用前瞻性收集的尿生物标志物数据库。在 AH 组中共有 53 名患者。19 名无 AH 病史和正常超声泌尿系的儿童被作为对照组。将初始同侧 DRF(Differential Renal Function)超过 50%的患者纳入 SnDRF 组,而其余患者则被归类为非 SnDRF。在两组中,未接受手术的患者被归类为非梗阻性扩张(NOD)。

结果

在 SnDRF 组的 20 名患者中有 6 名进行了肾盂成形术,在非 SnDRF 组的 33 名患者中有 19 名进行了肾盂成形术。SnDRF 组和非 SnDRF 组中,生物标志物水平不受 SnDRF 存在与否的影响(p=1.00,均为)。尿 NGAL 和 CA 19-9 可以以 83%和 100%的灵敏度、86%和 79%的特异性来确定 SnDRF 组的手术需求,而尿 IP-10 和 KIM-1 则分别以 84%和 83%的灵敏度、57%和 71%的特异性来确定 SnDRF 组的手术需求。尿 MCP-1 可以以 83%的灵敏度和 50%的特异性来区分 SnDRF 组中接受手术的患者。

结论

我们的结果表明,无论肾脏是否存在 SnDRF,生物标志物水平均不受影响。此外,在存在 SnDRF 的患者中,NGAL 和 CA 19-9 似乎可以更好地估计肾功能恶化前手术矫正的需求。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验